P2X7 receptor antagonism in the treatment of cancers

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.7, 2011-07, pp. : 875-880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

By Arulkumaran Nishkantha Unwin Robert J Tam Frederick WK

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 897-915

Informa Healthcare

Access to resources Recommend Favorite

Antagonism by the suramin analogue NF279 on human P2X 1 and P2X 7 receptors

By Klapperstuck M. Buttner C. Nickel P. Schmalzing G. Lambrecht G. Markwardt F.

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

The P2X₇ receptor as a therapeutic target

By Romagnoli Romeo Baraldi Pier Giovanni Cruz-Lopez Olga Lopez-Cara Carlota Preti Delia Borea Pier Andrea Gessi Stefania

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 647-661

Informa Healthcare

Access to resources Recommend Favorite

P2X₇-mediated chemoprevention of epithelial cancers

By Gorodeski George I

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1313-1332

Informa Healthcare

Access to resources Recommend Favorite

Prediction of the Conformation of the Human P2X7 Receptor

Letters in Drug Design & Discovery, Vol. 3, Iss. 10, 2006-12 ,pp. : 675-682

Bentham Science Publishers

Access to resources Recommend Favorite